Posted in | News

Massive Success for Nano Symposium

Delegates and speakers, Day 1.

Academia and Industry Meet to Develop Nano Development Strategy for the Future

More than 130 of the world’s leading experts in nanoscience and technology have taken part in the first-of-its-kind, International Symposium on Functional Nanomaterials in Industrial Applications.

Held at the University of Central Lancashire (UCLan) and organised in collaboration with leading UK powder and particle processing technology company Hosokawa Micron Ltd the conference has been declared a massive success and a huge leap towards a collaborative strategy for functional nanomaterials that will benefit mankind.

The event, attended by academic researchers and industrial organisations, created a unique platform to share information on the very latest in the research and development of nanomaterials and to discuss opportunities for collaboration to bring new materials to tomorrow’s marketplace.

Whilst evidence of nanoscience is already around us in every-day products, speakers at the two and a half day Symposium spoke of the research at the forefront of nanoscience and its potential for global impact:

  • Improvements in targeted delivery of drugs, directly to tumour sites using nanoparticle drug coated stents.
  • The green economy of using less of the world’s resources by making finer particles, that create less waste.
  • Addition of Nano Silica in tyres to improve tyre durability and enhanced traction in the wet.
  • Nanotechnology for the removal of harmful organics and heavy metals to purify water.
  • Depletion of the world’s resources and new nanoscience options for the recovery from waste of increasingly precious metals such as lithium for use in batteries – to run the new generation of electric cars.
  • Opportunities for student research and technology enabling, developmental funding and collaboration projects.

Lively open forum discussions ranged from issues relating to IP ownership, shared access to academic infrastructure, student education and skills requirements to opportunities to make money by creating high demand products and for future collaborations for the development of new materials.

Unanimously positive feedback from the event requested a follow up symposium. The Chair of the event, Dr Tapas Sen, Reader in Nanomaterials Chemistry, in collaboration with Hosokawa Micron Ltd. is already making plans for the next academic-industry meet in 2017.

Prof Mauro Magnani, University of Urbino, Italy said, ‘I would like to congratulate you and your colleagues for the excellent symposium and the perfect climate for discussion and collaborations’.

Mr. Iain Crosley, MD, Hosokawa Micron Ltd, added, ‘We were pleased to be involved in such a well organised event and have the name Hosokawa Micron associated with it. The discussions that took place throughout the event gave us a great understanding of the current areas of interest and the challenges the researchers are facing’.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hosokawa Micron Ltd. (2019, February 11). Massive Success for Nano Symposium. AZoNano. Retrieved on November 23, 2024 from https://www.azonano.com/news.aspx?newsID=34593.

  • MLA

    Hosokawa Micron Ltd. "Massive Success for Nano Symposium". AZoNano. 23 November 2024. <https://www.azonano.com/news.aspx?newsID=34593>.

  • Chicago

    Hosokawa Micron Ltd. "Massive Success for Nano Symposium". AZoNano. https://www.azonano.com/news.aspx?newsID=34593. (accessed November 23, 2024).

  • Harvard

    Hosokawa Micron Ltd. 2019. Massive Success for Nano Symposium. AZoNano, viewed 23 November 2024, https://www.azonano.com/news.aspx?newsID=34593.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.